348 related articles for article (PubMed ID: 9544207)
1. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
4. The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase.
Ahmed S; James K; Owen CP
Biochem Biophys Res Commun; 2002 May; 294(1):180-3. PubMed ID: 12054760
[TBL] [Abstract][Full Text] [Related]
5. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ
Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021
[TBL] [Abstract][Full Text] [Related]
10. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
Woo LW; Purohit A; Reed MJ; Potter BV
J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
[No Abstract] [Full Text] [Related]
11. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
13. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
[TBL] [Abstract][Full Text] [Related]
14. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
15. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE.
Purohit A; Woo LW; Potter BV; Reed MJ
Cancer Res; 2000 Jul; 60(13):3394-6. PubMed ID: 10910045
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
18. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
19. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
Billich A; Nussbaumer P; Lehr P
J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
